Universal Corporation Reports First Quarter Fiscal Year 2026 Results
Revenue of
Operating Income of
FINANCIAL HIGHLIGHTS |
|
|
|
||||
|
Three Months Ended |
||||||
(in millions of dollars, except per share data) |
|
2025 |
|
|
|
2024 |
|
|
|
|
|
||||
Consolidated Results |
|
|
|
||||
Sales and other operating revenue |
$ |
593.8 |
|
|
$ |
597.1 |
|
Cost of goods sold |
$ |
479.6 |
|
|
$ |
501.1 |
|
Gross profit margin percentage |
|
19.2 |
% |
|
|
16.1 |
% |
Selling, general and administrative expenses |
$ |
79.2 |
|
|
$ |
78.7 |
|
Restructuring and impairment costs |
$ |
1.1 |
|
|
$ |
— |
|
Operating income |
$ |
33.8 |
|
|
$ |
17.2 |
|
Adjusted operating income (non-GAAP)* |
$ |
34.9 |
|
|
$ |
17.2 |
|
Net income attributable to |
$ |
8.5 |
|
|
$ |
0.1 |
|
Adjusted net income attributable to |
$ |
9.6 |
|
|
$ |
0.1 |
|
Diluted earnings (loss) per share |
$ |
0.34 |
|
|
$ |
0.01 |
|
Adjusted diluted earnings (loss) per share (non-GAAP)* |
$ |
0.38 |
|
|
$ |
0.01 |
|
Segment Results |
|
|
|
||||
Tobacco operations sales and other operating revenues |
$ |
504.7 |
|
|
$ |
512.0 |
|
Tobacco operations operating income |
$ |
35.7 |
|
|
$ |
14.5 |
|
Ingredients operations sales and other operating revenues |
$ |
89.1 |
|
|
$ |
85.1 |
|
Ingredients operations operating income (loss) |
$ |
1.7 |
|
|
$ |
2.9 |
|
*See Reconciliation of Certain non-GAAP Financial Measures in Other Items below |
First Quarter 2026 Highlights
Consolidated Results
-
Revenues down
$3 million to$594 million on lower tobacco sales volumes. -
Operating income up
$17 million to$34 million on favorable product mix in the Tobacco Operations segment.
Tobacco Operations Segment
-
Revenues down
$7 million and segment operating income up$21 million . - Quarter results reflected seasonal patterns with lower tobacco sales and higher working capital outlays for tobacco purchases.
- Tobacco sales volumes down 8% on lower consolidated sales of carryover crop tobacco.
- Tobacco sales prices up 2% on product mix.
-
Operating income up on a favorable product mix in
Asia . - Low uncommitted tobacco inventory levels at about 11% at quarter end.
-
Outlook
-
Flue-cured and burley tobacco crop sizes (excluding
China ) are expected to increase by about 25% and 45%, respectively, in fiscal year 2026. - Tobacco is expected to move to a more balanced position during fiscal year 2026. However, given current expected crop sizes, we believe it is likely that flue-cured and burley tobacco will be in oversupply positions by the end of the fiscal year.
-
Flue-cured and burley tobacco crop sizes (excluding
Ingredients Operations Segment
- Higher revenues on increased sales volumes.
- Lower operating income reflected a less favorable product mix, some curtailed demand due to tariff uncertainty, and higher fixed costs, including additional depreciation, from our recently expanded production facility.
- Continued high level of interest in value-added products.
- Focus on organic growth.
Select Balance Sheet Items, Liquidity, and Debt
- Increased working capital usage on seasonal tobacco purchases during the quarter.
-
Cash balance of
$178.4 million , up$76.7 million quarter-over-quarter. -
Total debt up
$40.7 million quarter-over-quarter. -
Net debt down
$47.1 million quarter-over-quarter. -
Approximately
$355 million available under revolving credit facility as of quarter end.
Additional Items
-
Restructuring and impairment costs of
$1.1 million primarily related to previously announced consolidation of the Company’s European sheet operations.
Sustainability Update
Other Items
Reconciliation of Certain Non-GAAP Financial Measures
References to adjusted operating income (loss), adjusted net income (loss) attributable to
References to net debt, net capitalization, and net debt to net capitalization ratio are also references to non-GAAP financial measures. These measures are not financial measures calculated in accordance with GAAP and should not be considered substitutes for total debt, total capitalization, total debt to total capitalization ratio, or any other operating or financial performance measures calculated in accordance with GAAP, and may not be comparable to similarly-titled measures reported by other companies. Reconciliations of net debt to total debt and net capitalization to total capitalization are provided below. Management believes these non-GAAP measures are meaningful indicators of liquidity and financial position.
The following tables set forth certain non-recurring items included in reported results to reconcile adjusted operating income to consolidated operating income and adjusted net income to net income attributable to
Adjusted Operating Income Reconciliation |
|
|||||
|
Three Months Ended |
|||||
(in thousands) |
|
2025 |
|
|
|
2024 |
As Reported: Consolidated operating income |
$ |
33,813 |
|
|
$ |
17,225 |
Restructuring and impairment costs(1) |
|
1,122 |
|
|
|
— |
As Adjusted operating income (non-GAAP) |
$ |
34,935 |
|
|
$ |
17,225 |
|
|
|
|
|||
Adjusted Net Income Attributable to |
||||||
|
|
|
|
|||
(in thousands except for per share amounts) |
Three Months Ended |
|||||
|
|
2025 |
|
|
|
2024 |
As Reported: Net income attributable to |
$ |
8,497 |
|
|
$ |
130 |
Restructuring and impairment costs(1) |
|
1,122 |
|
|
|
— |
Total of non-GAAP adjustments to income before income taxes |
|
1,122 |
|
|
|
— |
Non-GAAP adjustments to income taxes |
|
|
|
|||
Income tax benefit from restructuring and impairment costs(2) |
|
(35 |
) |
|
|
— |
Total of income tax impacts for non-GAAP adjustments to income before income taxes |
|
(35 |
) |
|
|
— |
As adjusted: Net income attributable to |
$ |
9,584 |
|
|
$ |
130 |
As reported: Diluted earnings per share |
$ |
0.34 |
|
|
$ |
0.01 |
As adjusted: Diluted earnings per share (non-GAAP) |
$ |
0.38 |
|
|
$ |
0.01 |
|
|
|
|
(1) |
Restructuring and impairment costs are included in Consolidated operating income in the consolidated statements of income, but excluded for purposes of Adjusted operating income, Adjusted net income available to |
|
(2) |
The income tax effect of non-GAAP adjustments was determined based on the timing and nature of the specific non-GAAP adjustments and their relevant jurisdictional income tax rates (foreign, state, and local) and the applicable |
The following table reconciles total debt to net debt and net capitalization:
Net Debt and Net Capitalization Reconciliation |
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
(in thousands) |
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
Add: Notes payable and overdrafts |
|
$ |
621,275 |
|
|
$ |
581,087 |
|
|
$ |
455,039 |
|
Add: Long-term obligations |
|
|
618,057 |
|
|
|
617,502 |
|
|
|
617,918 |
|
Add: Current portion of long-term obligations |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total Debt |
|
|
1,239,332 |
|
|
|
1,198,589 |
|
|
|
1,072,957 |
|
Add: Customer advances and deposits |
|
|
4,557 |
|
|
|
15,660 |
|
|
|
3,763 |
|
Less: Cash and cash equivalents |
|
|
178,435 |
|
|
|
101,700 |
|
|
|
260,115 |
|
Net Debt (non-GAAP) |
|
$ |
1,065,454 |
|
|
$ |
1,112,549 |
|
|
$ |
816,605 |
|
Add: |
|
|
1,458,917 |
|
|
|
1,413,457 |
|
|
|
1,458,556 |
|
Net Capitalization (non-GAAP) |
|
$ |
2,524,371 |
|
|
$ |
2,526,006 |
|
|
$ |
2,275,161 |
|
|
|
|
|
|
|
|
||||||
Net Debt/Net Capitalization (non-GAAP) |
|
|
42 |
% |
|
|
44 |
% |
|
|
36 |
% |
Investor Conference Call
At
About
CAUTIONARY STATEMENTS REGARDING FORWARD-LOOKING INFORMATION
This release includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Among other things, these statements include statements made in Mr. Wigner’s quotations, statements regarding expectations with respect to our fiscal year 2026 performance, our strategic plans, ingredients business, tobacco business, including expectations with respect to size, shipments and sales and purchases of tobacco crops. These forward-looking statements are generally identified by the use of words such as we “expect,” “believe,” “anticipate,” “could,” “should,” “may,” “plan,” “will,” “predict,” “estimate,” and similar expressions or words of similar import. These forward-looking statements are based upon management’s current knowledge and assumptions about future events and involve risks and uncertainties that could cause actual results, performance, or achievements to be materially different from any anticipated results, prospects, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include, but are not limited to: product purchased not meeting quality and quantity requirements; reliance on a few large customers; anticipated levels of demand for and supply of our products and services; tobacco growing conditions and customer requirements; major shifts in customer requirements for leaf tobacco; higher inflation rates, tariffs and other pressures on costs; weather and other conditions; exposure to certain legal, regulatory and financial risks related to climate change; industry-specific risks related to our plant-based ingredients businesses; disruption of our supply chain for our plant-based ingredients; success in pursuing strategic investments or acquisitions and integration of new businesses and the impact of these new businesses on future results; our ability to maintain effective information technology systems and safeguard confidential information; our inability to attract, develop, retain, motivate, and maintain good relationships with our workforce; our dependence on a seasonal workforce; epidemics, pandemics or similar widespread public health concerns; government efforts to regulate the production and consumption of tobacco products; government actions on the sourcing of leaf tobacco; economic and political conditions in the countries in which we and our customers operate, including the ongoing impacts from international conflicts; sustainability considerations from governments and other stakeholders; changes in tax laws in the countries where we do business; material weaknesses in our internal control over financial reporting; our inability to use a Form S-3 registration statement; failure of our customers or suppliers to repay extensions of credit; changes in exchange rates; changes in interest rates; and low investment performance by our defined benefit pension plan assets and changes in pension plan valuation assumptions.Please also refer to the risks and uncertainties as discussed in Part I, Item 1A. “Risk Factors” of Universal’s Annual Report on Form 10-K for the fiscal year ended
CONSOLIDATED STATEMENTS OF INCOME (in thousands of dollars, except per share data) |
||||||||
|
|
Three Months Ended |
||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
(Unaudited) |
||||||
Sales and other operating revenues |
|
$ |
593,762 |
|
|
$ |
597,050 |
|
Costs and expenses |
|
|
|
|
||||
Cost of goods sold |
|
|
479,635 |
|
|
|
501,129 |
|
Selling, general and administrative expenses |
|
|
79,192 |
|
|
|
78,696 |
|
Restructuring and impairment costs |
|
|
1,122 |
|
|
|
— |
|
Operating income |
|
|
33,813 |
|
|
|
17,225 |
|
Equity in pretax earnings (loss) of unconsolidated affiliates |
|
|
2,435 |
|
|
|
140 |
|
Other non-operating income (expense) |
|
|
586 |
|
|
|
464 |
|
Interest income |
|
|
647 |
|
|
|
808 |
|
Interest expense |
|
|
17,777 |
|
|
|
20,734 |
|
Income (loss) before income taxes and other items |
|
|
19,704 |
|
|
|
(2,097 |
) |
Income taxes |
|
|
5,337 |
|
|
|
727 |
|
Net income (loss) |
|
|
14,367 |
|
|
|
(2,824 |
) |
Less: net loss (income) attributable to noncontrolling interests in subsidiaries |
|
|
(5,870 |
) |
|
|
2,954 |
|
Net income (loss) attributable to |
|
$ |
8,497 |
|
|
$ |
130 |
|
|
|
|
|
|
||||
Earnings per share: |
|
|
|
|
||||
Basic |
|
$ |
0.34 |
|
|
$ |
0.01 |
|
Diluted |
|
$ |
0.34 |
|
|
$ |
0.01 |
|
See accompanying notes. |
CONSOLIDATED BALANCE SHEETS (in thousands of dollars) |
||||||||||||
|
|
|
|
|
|
|
||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
(Unaudited) |
|
(Unaudited) |
|
|
||||||
ASSETS |
|
|
|
|
|
|
||||||
Current assets |
|
|
|
|
|
|
||||||
Cash and cash equivalents |
|
$ |
178,435 |
|
|
$ |
101,700 |
|
|
$ |
260,115 |
|
Accounts receivable, net |
|
|
424,157 |
|
|
|
435,941 |
|
|
|
625,876 |
|
Advances to suppliers, net |
|
|
79,154 |
|
|
|
100,451 |
|
|
|
169,385 |
|
Accounts receivable—unconsolidated affiliates |
|
|
127,701 |
|
|
|
60,991 |
|
|
|
7,143 |
|
Inventories—at lower of cost or net realizable value: |
|
|
|
|
|
|
||||||
Tobacco |
|
|
1,219,769 |
|
|
|
1,202,341 |
|
|
|
806,332 |
|
Other |
|
|
205,036 |
|
|
|
187,743 |
|
|
|
189,610 |
|
Prepaid income taxes |
|
|
22,715 |
|
|
|
23,576 |
|
|
|
19,595 |
|
Other current assets |
|
|
89,360 |
|
|
|
85,712 |
|
|
|
78,041 |
|
Total current assets |
|
|
2,346,327 |
|
|
|
2,198,455 |
|
|
|
2,156,097 |
|
|
|
|
|
|
|
|
||||||
Property, plant and equipment |
|
|
|
|
|
|
||||||
Land |
|
|
26,266 |
|
|
|
25,926 |
|
|
|
26,113 |
|
Buildings |
|
|
337,290 |
|
|
|
326,988 |
|
|
|
333,398 |
|
Machinery and equipment |
|
|
739,899 |
|
|
|
702,153 |
|
|
|
723,935 |
|
|
|
|
1,103,455 |
|
|
|
1,055,067 |
|
|
|
1,083,446 |
|
Less accumulated depreciation |
|
|
(728,180 |
) |
|
|
(680,011 |
) |
|
|
(710,472 |
) |
|
|
|
375,275 |
|
|
|
375,056 |
|
|
|
372,974 |
|
Other assets |
|
|
|
|
|
|
||||||
Operating lease right-of-use assets |
|
|
38,428 |
|
|
|
30,582 |
|
|
|
34,260 |
|
|
|
|
213,864 |
|
|
|
213,810 |
|
|
|
213,840 |
|
Other intangibles, net |
|
|
55,237 |
|
|
|
66,074 |
|
|
|
57,836 |
|
Investments in unconsolidated affiliates |
|
|
87,988 |
|
|
|
75,531 |
|
|
|
79,317 |
|
Deferred income taxes |
|
|
20,461 |
|
|
|
18,287 |
|
|
|
16,539 |
|
Pension asset |
|
|
13,006 |
|
|
|
12,075 |
|
|
|
12,819 |
|
Other noncurrent assets |
|
|
38,721 |
|
|
|
43,098 |
|
|
|
45,870 |
|
|
|
|
467,705 |
|
|
|
459,457 |
|
|
|
460,481 |
|
|
|
|
|
|
|
|
||||||
Total assets |
|
$ |
3,189,307 |
|
|
$ |
3,032,968 |
|
|
$ |
2,989,552 |
|
See accompanying notes. |
CONSOLIDATED BALANCE SHEETS (in thousands of dollars) |
||||||||||||
|
|
|
|
|
|
|
||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
2025 |
|
|
|
(Unaudited) |
|
(Unaudited) |
|
|
||||||
LIABILITIES AND SHAREHOLDERS’ EQUITY |
|
|
|
|
|
|
||||||
Current liabilities |
|
|
|
|
|
|
||||||
Notes payable and overdrafts |
|
$ |
621,275 |
|
|
$ |
581,087 |
|
|
$ |
455,039 |
|
Accounts payable |
|
|
119,803 |
|
|
|
79,747 |
|
|
|
98,036 |
|
Accounts payable—unconsolidated affiliates |
|
|
76 |
|
|
|
— |
|
|
|
1,999 |
|
Customer advances and deposits |
|
|
4,557 |
|
|
|
15,660 |
|
|
|
3,763 |
|
Accrued compensation |
|
|
22,577 |
|
|
|
20,903 |
|
|
|
44,646 |
|
Income taxes payable |
|
|
15,528 |
|
|
|
10,766 |
|
|
|
12,586 |
|
Current portion of operating lease liabilities |
|
|
11,233 |
|
|
|
9,588 |
|
|
|
10,742 |
|
Accrued expenses and other current liabilities |
|
|
147,639 |
|
|
|
128,305 |
|
|
|
123,350 |
|
Current portion of long-term debt |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Total current liabilities |
|
|
942,688 |
|
|
|
846,056 |
|
|
|
750,161 |
|
|
|
|
|
|
|
|
||||||
Long-term debt |
|
|
618,057 |
|
|
|
617,502 |
|
|
|
617,918 |
|
Pensions and other postretirement benefits |
|
|
36,307 |
|
|
|
43,386 |
|
|
|
35,336 |
|
Long-term operating lease liabilities |
|
|
24,945 |
|
|
|
17,457 |
|
|
|
20,608 |
|
Other long-term liabilities |
|
|
26,032 |
|
|
|
27,167 |
|
|
|
22,901 |
|
Deferred income taxes |
|
|
41,689 |
|
|
|
37,901 |
|
|
|
42,090 |
|
Total liabilities |
|
|
1,689,718 |
|
|
|
1,589,469 |
|
|
|
1,489,014 |
|
|
|
|
|
|
|
|
||||||
Shareholders’ equity |
|
|
|
|
|
|
||||||
|
|
|
|
|
|
|
||||||
Preferred stock: |
|
|
|
|
|
|
||||||
Series A Junior Participating Preferred Stock, no par value, 500,000 shares authorized, none issued or outstanding |
|
|
— |
|
|
|
— |
|
|
|
— |
|
Common stock, no par value, 100,000,000 shares authorized 24,807,613 shares issued and outstanding at |
|
|
355,498 |
|
|
|
347,152 |
|
|
|
351,626 |
|
Retained earnings |
|
|
1,174,758 |
|
|
|
1,153,026 |
|
|
|
1,186,981 |
|
Accumulated other comprehensive loss |
|
|
(71,339 |
) |
|
|
(86,721 |
) |
|
|
(80,051 |
) |
|
|
|
1,458,917 |
|
|
|
1,413,457 |
|
|
|
1,458,556 |
|
Noncontrolling interests in subsidiaries |
|
|
40,672 |
|
|
|
30,042 |
|
|
|
41,982 |
|
Total shareholders' equity |
|
|
1,499,589 |
|
|
|
1,443,499 |
|
|
|
1,500,538 |
|
|
|
|
|
|
|
|
||||||
Total liabilities and shareholders' equity |
|
$ |
3,189,307 |
|
|
$ |
3,032,968 |
|
|
$ |
2,989,552 |
|
See accompanying notes. |
CONSOLIDATED STATEMENTS OF CASH FLOWS (in thousands of dollars) |
||||||||
|
|
Three Months Ended |
||||||
|
|
|
2025 |
|
|
|
2024 |
|
|
|
(Unaudited) |
||||||
CASH FLOWS FROM OPERATING ACTIVITIES: |
|
|
|
|
||||
Net income (loss) |
|
$ |
14,367 |
|
|
$ |
(2,824 |
) |
Adjustments to reconcile net income (loss) to net cash used by operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
13,582 |
|
|
|
14,564 |
|
Net provision for losses (recoveries) on advances to suppliers |
|
|
52 |
|
|
|
(751 |
) |
Inventory writedowns |
|
|
1,469 |
|
|
|
4,371 |
|
Stock-based compensation expense |
|
|
7,575 |
|
|
|
4,641 |
|
Foreign currency remeasurement (gain) loss, net |
|
|
(2,362 |
) |
|
|
7,171 |
|
Foreign currency exchange contracts |
|
|
(6,162 |
) |
|
|
(1,340 |
) |
Deferred income taxes |
|
|
(3,259 |
) |
|
|
(3,983 |
) |
Equity in net loss (income) of unconsolidated affiliates, net of dividends |
|
|
(1,943 |
) |
|
|
(154 |
) |
Restructuring and impairment costs |
|
|
1,122 |
|
|
|
— |
|
Restructuring payments |
|
|
(2,669 |
) |
|
|
(253 |
) |
Other, net |
|
|
(43 |
) |
|
|
644 |
|
Changes in operating assets and liabilities, net: |
|
|
(226,832 |
) |
|
|
(84,530 |
) |
Net cash used by operating activities |
|
|
(205,103 |
) |
|
|
(62,444 |
) |
|
|
|
|
|
||||
CASH FLOWS FROM INVESTING ACTIVITIES: |
|
|
|
|
||||
Purchase of property, plant and equipment |
|
|
(12,053 |
) |
|
|
(22,749 |
) |
Proceeds from sale of property, plant and equipment |
|
|
143 |
|
|
|
867 |
|
Net cash used by investing activities |
|
|
(11,910 |
) |
|
|
(21,882 |
) |
|
|
|
|
|
||||
CASH FLOWS FROM FINANCING ACTIVITIES: |
|
|
|
|
||||
Issuance of short-term debt, net |
|
|
165,861 |
|
|
|
162,140 |
|
Dividends paid to noncontrolling interests |
|
|
(7,203 |
) |
|
|
(8,330 |
) |
Dividends paid on common stock |
|
|
(20,020 |
) |
|
|
(19,659 |
) |
Other |
|
|
(4,016 |
) |
|
|
(3,397 |
) |
Net cash provided by financing activities |
|
|
134,622 |
|
|
|
130,754 |
|
|
|
|
|
|
||||
Effect of exchange rate changes on cash, restricted cash and cash equivalents |
|
|
711 |
|
|
|
(321 |
) |
Net increase (decrease) in cash, restricted cash and cash equivalents |
|
|
(81,680 |
) |
|
|
46,107 |
|
Cash, restricted cash and cash equivalents at beginning of year |
|
|
260,115 |
|
|
|
55,593 |
|
|
|
|
|
|
||||
Cash, restricted cash and cash equivalents at end of period |
|
$ |
178,435 |
|
|
$ |
101,700 |
|
See accompanying notes. |
NOTE 1. BASIS OF PRESENTATION
NOTE 2. EARNINGS PER SHARE
The following table sets forth the computation of basic and diluted earnings per share:
|
|
Three Months Ended |
||||
(in thousands, except share and per share data) |
|
|
2025 |
|
|
2024 |
|
|
|
|
|
||
Basic Earnings (Loss) Per Share |
|
|
|
|
||
Numerator for basic earnings (loss) per share |
|
|
|
|
||
Net income (loss) attributable to |
|
$ |
8,497 |
|
$ |
130 |
|
|
|
|
|
||
Denominator for basic earnings (loss) per share |
|
|
|
|
||
Weighted average shares outstanding |
|
|
24,999,570 |
|
|
24,876,220 |
|
|
|
|
|
||
Basic earnings (loss) per share |
|
$ |
0.34 |
|
$ |
0.01 |
|
|
|
|
|
||
Diluted Earnings (Loss) Per Share |
|
|
|
|
||
Numerator for diluted earnings (loss) per share |
|
|
|
|
||
Net income (loss) attributable to |
|
$ |
8,497 |
|
$ |
130 |
|
|
|
|
|
||
Denominator for diluted earnings (loss) per share: |
|
|
|
|
||
Weighted average shares outstanding |
|
|
24,999,570 |
|
|
24,876,220 |
Effect of dilutive securities |
|
|
|
|
||
Employee and outside director share-based awards |
|
|
132,287 |
|
|
189,886 |
Denominator for diluted earnings (loss) per share |
|
|
25,131,857 |
|
|
25,066,106 |
|
|
|
|
|
||
Diluted earnings (loss) per share |
|
$ |
0.34 |
|
$ |
0.01 |
NOTE 3. SEGMENT INFORMATION
Management regularly evaluates the Company’s global business activities, including product and service offerings to its customers, as well as senior management’s operational and financial responsibilities. Assessments include an analysis of how its Chief Operating Decision Maker (“CODM”) measures business performance and allocates resources. As a result of this analysis, senior management has determined the Company conducts operations across two reportable operating segments, Tobacco Operations and Ingredients Operations.
The Tobacco Operations segment activities involve contracting, procuring, processing, packing, storing, and shipping leaf tobacco for sale to, or for the account of, manufacturers of consumer tobacco products throughout the world. Through various operating subsidiaries located in tobacco-growing countries around the world and significant ownership interests in unconsolidated affiliates, the Company processes and/or sells flue-cured and burley tobaccos, dark air-cured tobaccos, and oriental tobaccos. Flue-cured, burley, and oriental tobaccos are used principally in the manufacture of cigarettes, and dark air-cured tobaccos are used mainly in the manufacture of cigars, pipe tobacco, and smokeless tobacco products. Some of these tobacco types are also used in the manufacture of next generation tobacco products that are intended to provide consumers with an alternative to traditional combustible products. The Tobacco Operations segment also provides physical and chemical product testing for tobacco customers. A substantial portion of the Company’s Tobacco Operations’ revenues are derived from sales to a limited number of large, multinational cigarette and cigar manufacturers.
The Ingredients Operations segment provides its customers with a broad variety of plant-based ingredients for both human and pet consumption. The Ingredients Operations segment utilizes a variety of value-added manufacturing processes converting raw materials into a wide spectrum of fruit and vegetable juices, concentrates, dehydrated products, botanical extracts, and flavorings. Customers for the Ingredients Operations segment include large multinational food and beverage companies, smaller independent manufacturers, and retail organizations.
Universal incurs corporate overhead expenses related to senior management, sales, finance, legal, and other functions that are centralized at its corporate headquarters, as well as functions performed at several sales and administrative offices around the world. These overhead expenses are currently allocated to the reportable operating segments, generally on the basis of projected annual financial and operational performance, including volumes planned to be purchased and/or processed. Management believes this method of allocation is currently representative of the value of the related services provided to the operating segments. The CODM, which has been identified as a group comprised of the Company’s Chief Executive Officer, Chief Operating Officer, and Chief Financial Officer, currently evaluates the performance of the operating segments based on operating income after allocated overhead expenses, plus equity in the pretax earnings of unconsolidated affiliates (“Segment Operating Income”). The CODM also uses Segment Operating Income for planning, forecasting, and allocating capital and other resources to the operating segments.
Reportable segment data as of, or for, each period presented in the consolidated statements of income and comprehensive income, the consolidated balance sheets, and the consolidated statements of cash flows is as follows:
Three Months Ended |
|
Three Months Ended |
|||||||||||||||||||||
|
Tobacco
|
|
Ingredients
|
|
Consolidated |
|
Tobacco
|
|
Ingredients
|
|
Consolidated |
||||||||||||
Sales and other operating revenues |
$ |
504,696 |
|
|
$ |
89,066 |
|
|
$ |
593,762 |
|
|
$ |
511,955 |
|
|
$ |
85,095 |
|
|
$ |
597,050 |
|
Cost of goods sold |
|
(407,867 |
) |
|
|
(71,768 |
) |
|
|
(479,635 |
) |
|
|
(434,765 |
) |
|
|
(66,364 |
) |
|
|
(501,129 |
) |
Selling, general and administrative expenses |
|
(44,754 |
) |
|
|
(12,037 |
) |
|
|
(56,791 |
) |
|
|
(46,548 |
) |
|
|
(12,779 |
) |
|
|
(59,327 |
) |
Corporate overhead allocated to the segments |
|
(18,840 |
) |
|
|
(3,561 |
) |
|
|
(22,401 |
) |
|
|
(16,328 |
) |
|
|
(3,041 |
) |
|
|
(19,369 |
) |
Equity in pretax earnings (loss) of unconsolidated affiliates(1) |
|
2,435 |
|
|
|
— |
|
|
|
2,435 |
|
|
|
140 |
|
|
|
— |
|
|
|
140 |
|
Segment operating income |
|
35,670 |
|
|
|
1,700 |
|
|
|
37,370 |
|
|
|
14,454 |
|
|
|
2,911 |
|
|
|
17,365 |
|
Deduct: Equity in pretax (earnings) loss of unconsolidated affiliates(1) |
|
|
(2,435 |
) |
|
|
|
|
|
|
(140 |
) |
|||||||||||
Restructuring and impairment costs (2) |
|
|
(1,122 |
) |
|
|
|
|
|
|
— |
|
|||||||||||
Consolidated operating income |
|
$ |
33,813 |
|
|
|
|
|
|
$ |
17,225 |
|
(1) |
Equity in pretax earnings (loss) of unconsolidated affiliates is included in segment operating income (Tobacco Operations), but is reported below consolidated operating income and excluded from that total in the consolidated statements of income and comprehensive income. |
|
(2) |
Restructuring and impairment costs are excluded from segment operating income, but are included in consolidated operating income in the consolidated statements of income and comprehensive income. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20250806651024/en/
Universal Corporation Investor Relations
Phone: (804) 359-9311
Fax: (804) 254-3584
Email: investor@universalleaf.com
Source: